Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

HMPV causes respiratory infections, mainly managed with supportive care, and lacks a vaccine or specific treatment.

Recurrent dry cough, wheezing, and respiratory discomfort are key symptoms for diagnosing pediatric asthma.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Tocilizumab might be an effective treatment for COVID-19.

Tislelizumab can cause cutaneous lupus erythematosus.

Ixekizumab has known and some unexpected side effects.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

The treatment combination is safe and effective for some patients with this type of breast cancer.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Bimekizumab effectively treated a man's chronic beard hair loss.

Abrocitinib may effectively treat Lichen Planopilaris.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Methylene blue, combined with ceramides, may reduce skin and hair side effects from GLP-1 therapy.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.